Elevated plasma concentrations of transforming growth factor-beta 1 in patients with unilateral ureteral obstruction

dc.contributor.buuauthorVuruşkan, Hakan
dc.contributor.buuauthorÇalışkan, Zulüf
dc.contributor.buuauthorÖzakın, Cüneyt
dc.contributor.buuauthorYavasçaoğlu, İsmet
dc.contributor.buuauthorOktay, Burçin
dc.contributor.buuauthorKordan, Yakup
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Üroloji Bölümü.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Mikrobiyoloji Bölümü.tr_TR
dc.date.accessioned2021-08-16T10:55:51Z
dc.date.available2021-08-16T10:55:51Z
dc.date.issued2005-12
dc.description.abstractWe measured plasma concentrations of TGF-beta 1 in patients with obstructive ureteral calculi and compared them with the plasma concentrations of healthy volunteers. The present study was a prospective study containing a homogenous group of patients with unilateral ureteral obstruction (UUO). The study consisted of patients with ureteral stones less than 7 mm in diameter that caused mild to moderate obstruction. All patients were referred by the emergency department of our hospital and examined between April 2003 and April 2004. The presence and characteristics of both stone and obstruction were determined by plain abdominal x-ray and gray-scale ultrasonography (US). Blood samples were collected from both patients and control individuals on admission and 1 week after conservative follow-up. The plasma TGF-beta 1 concentration was determined using a quantitative sandwich enzyme immunoassay specific for TGF-beta 1. There were 35 patients with 20 women and 15 men (average age 26.8 +/- 5.9 years), and 15 volunteers in the control group, with nine women and six men (average age 24.2 +/- 4.5 years). Average stone size was 5.6 mm +/- 1.2 mm (range 3.5-7) for the patient group. US showed the presence of mild hydronephrosis in 24 and moderate hydronephrosis in 11 patients. Plasma concentrations of TGF-beta 1 in patients with ureteral obstruction (1,117 +/- 5.8 ng/ml, range 36-2,442 ng/ml) were significantly higher than those in the healthy control group (32 +/- 4 ng/ml) on admission (P < 0.001). There was a significant increase in TGF-beta 1 plasma concentrations in the patient group (33,525 +/- 6.8 ng/ml, range 1,107-73,288 ng/ml) after 1 week follow-up (P < 0.001). Ureteral obstruction increases plasma TGF-beta 1 concentrations in patients with ureteral stones as in UUO models in animal studies. A concomitant treatment with an anti-fibrotic agent may reduce the incidence of renal injury during obstruction.en_US
dc.identifier.citationVuruskan, H. vd. (2005). "Elevated plasma concentrations of transforming growth factor-beta 1 in patients with unilateral ureteral obstruction". Urological Research, 33(6), 465-469.en_US
dc.identifier.endpage469tr_TR
dc.identifier.issn0300-5623
dc.identifier.issue6tr_TR
dc.identifier.scopus2-s2.0-28844452446tr_TR
dc.identifier.startpage465tr_TR
dc.identifier.urihttps://doi.org/10.1007/s00240-005-0509-z
dc.identifier.urihttps://link.springer.com/article/10.1007%2Fs00240-005-0509-z
dc.identifier.urihttp://hdl.handle.net/11452/21436
dc.identifier.volume33tr_TR
dc.identifier.wos000233869200011
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.journalUrological Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectTGF-beta 1en_US
dc.subjectObstructive nephropathyen_US
dc.subjectUreteral calculusen_US
dc.subjectInterstitial fibrosisen_US
dc.subjectUrınary transformıng growth-factor-beta-1en_US
dc.subjectOsteopontin expressionen_US
dc.subjectNephropathyen_US
dc.subjectMessenger-Rnaen_US
dc.subjectKidneyen_US
dc.subjectBetaen_US
dc.subjectReleaseen_US
dc.subjectUrology & nephrologyen_US
dc.subject.emtreeDiclofenacen_US
dc.subject.emtreeTransforming growth factor beta1en_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeBlood samplingen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeClinical trialen_US
dc.subject.emtreeControlled clinical trialen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeEmergency warden_US
dc.subject.emtreeEnzyme immunoassayen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFollow upen_US
dc.subject.emtreeGray scale echographyen_US
dc.subject.emtreeHospital admissionen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHydronephrosisen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeQuantitative assayen_US
dc.subject.emtreeUreter obstructionen_US
dc.subject.emtreeUreter stoneen_US
dc.subject.emtreeX rayen_US
dc.subject.meshAdulten_US
dc.subject.meshAnimalsen_US
dc.subject.meshCase-control studiesen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshKidneyen_US
dc.subject.meshMaleen_US
dc.subject.meshProspective studiesen_US
dc.subject.meshRenin-angiotensin systemen_US
dc.subject.meshTransforming growth factor betaen_US
dc.subject.meshTransforming growth factor beta1en_US
dc.subject.meshUreteral calculien_US
dc.subject.meshUreteral obstructionen_US
dc.subject.scopusUreter Obstruction; Hydronephrosis; Renal Circulationen_US
dc.subject.wosUrology & nephrologyen_US
dc.titleElevated plasma concentrations of transforming growth factor-beta 1 in patients with unilateral ureteral obstructionen_US
dc.typeArticle

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: